David Mokhtee, MD
Surgery of the Hand · Tulsa, OKNPI 1235321472
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (52.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Pylant Medical at 47.6% of the total. Reporting peaked in 2019 at $3,051 and has fallen 76.2% since, to $726 in 2025.
Across 92 payments — averaging $93.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$4K
- Arthrex$2K
- Axogen$928
- Endo Pharmaceuticals Inc.$329
- Endo USA, Inc.$288
- Amgen$174
- plus $823 from 12 others
What the payments were for
- Travel & lodging$2293%
- Food & beverage$3,87245%
- Education$4,49152%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 30 | $4,087 |
| Arthrex | 15 | $1,963 |
| Axogen | 8 | $928 |
| Endo Pharmaceuticals Inc. | 11 | $329 |
| Endo USA, Inc. | 6 | $288 |
| Amgen | 3 | $174 |
| Bioventus LLC | 2 | $168 |
| KCI USA, Inc. | 1 | $121 |
| P Bar Medical LLC | 4 | $120 |
| Johnson & Johnson | 3 | $101 |
| Ensemble Orthopedics, Inc | 1 | $86 |
| Biocomposites Inc | 1 | $42 |
| Organogenesis Inc. | 1 | $41 |
| Stryker | 1 | $35 |
| Pacira Therapeutics, Inc. | 2 | $32 |
| Smith+Nephew | 1 | $31 |
| Skeletal Dynamics Inc | 1 | $28 |
| Polynovo North America LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few surgery of the hand providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 183 | $1,087 |
| Meloxicam | 103 | $666 |
| Celecoxib | 16 | $438 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 36 | $275 |
Paid to pharmacies, not to this prescriber.
Other surgery of the hand in Tulsa
- Elizabeth WeldinTulsa$4K
- Carolyn BergTulsa$2K
- Jeffrey StrombergTulsa$2K
- Rachel HeinOklahoma City$17K
- Zachary HurwitzEdmond$9K
- Margaret PorembskiOklahoma City$3K
- Daron HittOklahoma City$1K
- Robert UnsellOklahoma City$817
- Stephen MihalskyEdmond$303
- Ashok KrishnamurthyOklahoma City$239
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.